On January 18, 2023 , Imexpharm organized its annual program with the participation of over 800 members from the Office and Production Divisions in Đồng Tháp, Ho Chi Minh City, and Bình Dương. A separate event for the Business Division will be combined with the National Sales and Marketing Conference, scheduled for early March.
After a two-year hiatus due to the pandemic, this year’s program took place in a warm, heartfelt, and emotional atmosphere. The year 2022 marked the conclusion of the 2018–2022 term with the strategic theme "Aspiration to Lead." This message embodies the vision Imexpharm’s leadership aims to convey to its employees, shareholders, investors, customers, and partners.
During the program, the Imexpharm family reflected on the past five years of growth and celebrated the top 10 highlights of 2022, particularly the remarkable achievements in revenue and profit, which exceeded expectations and saw significant growth compared to the previous year. In 2022, Imexpharm recorded total revenue of VND 1,643 billion, reflecting a growth rate of 27.3% compared to 2021 and surpassing the General Meeting of Shareholders’ plan by 13%. Pre-tax profit reached VND 301.8 billion, an increase of 26.3% and exceeding the target by 9.7%. Activities across production, business, marketing, research and development, human resources, and finance all delivered positive results, laying the foundation for Imexpharm to receive numerous prestigious awards in 2022.
A special highlight of the program was the insightful sharing by Mr. Nguyễn Quốc Định, Chairman of the Board, and People’s Doctor, Pharmacist Trần Thị Đào, General Director of Imexpharm, who discussed the company’s strategic directions for 2023 and the vision for the upcoming term. They addressed the new economic and political context, the growth potential of Vietnam’s pharmaceutical industry, and Imexpharm’s competitive advantages and internal strengths.
"I always base my decisions on the sustainable development of Imexpharm and ensuring job security for our employees," the General Director emphasized, reflecting her deep commitment to the company’s values. This ethos was highlighted during the program by recognizing and honoring employees who have dedicated 10 and 20 years of service to the company, a heartfelt gesture of gratitude from the leadership for their contributions.
The program concluded with well-wishes for health and prosperity from the leadership team to all employees and their families, followed by a warm gathering where Imexpharm members had the chance to reconnect, share stories, and reflect on the past year.
With the achievements and accolades earned during the previous term, combined with the leadership's vision and the dedication of every member, Imexpharm is well-positioned for ambitious goals in the next phase.
The race for 2023–2027 has officially begun. Wishing the leadership and the Imexpharm family smooth sailing, success, and prosperity.
Welcome New Year, Year of the Cat 2023!